DEFA3 and chronic myelogenous leukemia, BCR-ABL1 positive: The dysregulation of KLF3, DEFA3, or MYC was observed in 31 CML patients (Figure 2F), and three patients, who may have a greater blast crisis risk, were observed with a dysregulation of both KLF3 and DEFA3.